iph5301 - SERP Analysis

https://www.innate-pharma.com/products/iph5301

https://www.annalsofoncology.org/article/S0923-7534(24)02581-X/fulltext

https://www.esmoiotech.org/article/S2590-0188(22)00279-9/fulltext

https://www.innate-pharma.com/sites/default/files/poster_sitc_2019_iph5301_120x120.pdf

https://clin.larvol.com/trial-detail/NCT05143970

https://www.medchemexpress.com/iph5301.html?srsltid=AfmBOoq8H3g0MwbnV2fYZpN6qjzmiR9DR2bG-2Jcrt9O35hqvY4CteQR

https://www.biospace.com/innate-pharma-to-present-adenosine-franchise-iph5201-and-iph5301-at-esmo-io-2022

https://web.expasy.org/abcd/ABCD_AQ741

https://antibodysystem.com/product/14564.html

https://pubmed.ncbi.nlm.nih.gov/31116985/

https://www.esmoiotech.org/article/S2590-0188(22)00279-9/pdf

https://clin.larvol.com/abstract-detail/ESMO%202024/71883732

https://www.researchgate.net/publication/384087810_1003P_A_first-in-human_FIH_phase_I_study_of_IPH5301_an_anti-CD73_monoclonal_antibody_mAb_in_patients_with_advanced_solid_tumors_AST_CHANCES_NCT05143970

https://www.creative-diagnostics.com/human-cd73-antibody-item-dmab-cdb25413-130778.html

https://pryzm.ozmosi.com/product/26613

https://www.researchgate.net/publication/366161255_199TiP_A_first-in-human_phase_I_study_of_IPH5301_an_anti-CD73_monoclonal_antibody_alone_or_in_combination_with_chemotherapy_and_trastuzumab_in_patients_with_advanced_solid_tumors_CHANCES

https://www.oncologypipeline.com/apexonco/arcus-gets-anti-cd73-small-molecule-buy

https://pmc.ncbi.nlm.nih.gov/articles/PMC7939394/

https://www.sciencedirect.com/science/article/pii/S2211124719305716

https://file.medchemexpress.com/batch_PDF/HY-P991443/IPH5301-DataSheet-MedChemExpress.pdf

https://www.cell.com/cell-reports/pdf/S2211-1247(19)30571-6.pdf

https://www.iedb.org/details_v3.php?type=assay&id=6250626

https://m.x-mol.net/paper/detail/1858763033847099392

https://www.acrobiosystems.com/P2761-Human-CD73--NT5E-Protein-His-Tag-%28HPLC-verified%29-%28active-enzyme%29.html?srsltid=AfmBOooGezVU9EdQ_b7oIFuTwcWY29VU3rbH1hOOyE76eLi-bXdaW9L0

https://www.labroots.com/companies/creative-biolabs/products/CB-LX074-A?srsltid=AfmBOoqz1rl-9zkvTyieQThf7Scjx5vSxJXbNLATpjr6xi_4sahWJFOI

https://www.mybiosource.com/monoclonal-human-recombinant-antibody/cd73-nt5e/1581209?utm_source=TDSQR

https://www.acrobiosystems.com/P2871-Biotinylated-Human-CD73--NT5E-Protein-HisAvitag%E2%84%A2.html?srsltid=AfmBOoquSNhMmE-_7frr8GDdyclU0hKjhr4zL4fLvRM3MiWl1IcovLsp

https://www.medchemexpress.eu/search.html?q=IPH5301&ft=&fa=&fp=

https://firstwordpharma.com/river/tag/fw_company/Innate%20Pharma

https://s28.q4cdn.com/864950573/files/doc_downloads/key/2022/220110-Clinical-Trials-Appendix.pdf

https://www.oncopacacorse.org/actualites/lancement-des-premiers-essais-cliniques-chez-lhomme-avec-iph5301-une-nouvelle-molecule/

https://essaisclic.girci-idf.fr/EssaiClinique/Detail/Essai/NCT05143970

https://www.cancerbiomed.org/highwire/markup/9888/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed

https://jitc.bmj.com/content/13/1/e009245

https://s28.q4cdn.com/864950573/files/doc_presentation/2024/06/240626_iph_corporate-presentation-june.pdf

https://innatepharma2021ir.q4web.com/English/investors/resources/investor-email-alerts/default.aspx

https://www.cancer.fr/personnes-malades/registre-des-essais-cliniques/etude-chances-etude-de-phase-1-evaluant-le-profil-de-securite-d-un-anticorps-anti-cd73-l-iph5301-seul-ou-en-association-avec-la-chimiotherapi

https://www.oncodistinct.net/clinical-trials/

https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-025-00784-0/tables/1

https://synapse.patsnap.com/drug/9e160e43dd314f7ab5122ac24ef61b76

https://search.library.ucla.edu/discovery/fulldisplay?docid=cdi_doaj_primary_oai_doaj_org_article_5587ee70bc8c4270948f7103cc944bcd&context=PC&vid=01UCS_LAL:UCLA&lang=en&search_scope=ArticlesBooksMore&adaptor=Primo%20Central&tab=Articles_books_more_slot&query=creator%2Cexact%2C%20Gauthier%2C%20Laurent%20%2CAND&facet=creator%2Cexact%2C%20Gauthier%2C%20Laurent%20&mode=advanced&offset=0

https://www.caducee.net/actualite-medicale/15717/cancer-l-ipc-lance-une-etude-visant-a-evaluer-l-efficacite-de-l-iph5301-un-anticorps-anti-cd73-dans-le-traitement-des-tumeurs-solides.html

https://www.unicancer.fr/fr/actualite/ouverture-dune-etude-de-premiere-administration-a-lhomme-dune-therapie-innovante/

https://www.perplexity.ai/app/finance/IPH.PA/financials

https://www.institutpaolicalmettes.fr/etude-de-premiere-administration-a-lhomme/

https://innatepharma2021ir.q4web.com/English/investors/events-and-presentations/default.aspx

https://twitter.com/InnatePharma/status/1835720535390446011

https://www.labourseetlavie.com/actualites-economiques-et-financieres-actualites/innate-pharma-presentera-sa-franchise-adenosine-iph5201-et-iph5301-au-congres-de-lesmo-io-2022

https://go.drugbank.com/indications/DBCOND0139388/clinical_trials/DB00072?phase=1&status=recruiting

https://www.facebook.com/photo.php?fbid=1082543603874143&id=100063555400821&set=a.540581578070351

https://leitir.is/discovery/fulldisplay/cdi_doaj_primary_oai_doaj_org_article_5587ee70bc8c4270948f7103cc944bcd/354ILC_NETWORK:10000_UNION

https://librarysearch.ohsu.edu/discovery/fulldisplay?docid=cdi_doaj_primary_oai_doaj_org_article_5587ee70bc8c4270948f7103cc944bcd&context=PC&vid=01ALLIANCE_OHSU:OHSU&lang=en&search_scope=Everything&adaptor=Primo%20Central&tab=Everything&query=creator%2Cexact%2CPerrot%2C%20Ivan%20%2CAND&facet=creator%2Cexact%2CPerrot%2C%20Ivan%20&mode=advanced&offset=0

https://www.a-z.lu/discovery/fulldisplay?docid=cdi_doaj_primary_oai_doaj_org_article_5587ee70bc8c4270948f7103cc944bcd&context=PC&vid=352LUX_BIBNET_NETWORK:BIBNET_UNION&lang=fr&search_scope=DN_and_CI&adaptor=Primo%20Central&query=sub%2Cexact%2CADP-ribosyl%20Cyclase%201%20%2CAND&facet=citing%2Cexact%2Ccdi_FETCH-LOGICAL-c374t-c490b136d6238061714c4690afb5d6a50f9c8541d961cce05dae9c31a9f921e3&offset=0

https://www.santelog.com/actualites-sante-nasdaq/innate-pharma-announces-publication-next-generation-immunotherapies

https://archimaid.fr/recherche/2150?action=search&page=6

https://pdbj.org/mine/summary/6hxw

https://www.biospace.com/innate-pharma-announces-iph5201-phase-2-study-in-lung-cancer

https://www.globaldata.com/company-profile/innate-pharma-sa/

https://shuimubio.com/news/case-study-cryo-em-enabled-conformational-epitope-mapping-inspires-novel-and-highly-differentiated-antibody-development

https://www.medecinesciences.org/articles/medsci/full_html/2020/02/msc190300/msc190300.html

https://www.institutpaolicalmettes.fr/wp-content/uploads/2022/03/CP-Etude-de-premiere-administration-a-l_homme.pdf

https://www.cell.com/cell-reports/fulltext/S2211-1247(19)30571-6

https://stockanalysis.com/stocks/ipha/company/

https://www.sciencedirect.com/science/article/pii/S1471489220300394

https://www.sec.gov/Archives/edgar/data/1598599/000115752322000594/a52712901ex991.htm

https://www.orega-biotech.com/wp-content/uploads/2024/06/Gros-2020.pdf

https://m.x-mol.net/paper/detail/5692515

https://www.medifind.com/conditions/undefined/629/clinical-trial/523688448

https://www.amazon.in/Limited-Luxury-Cases-IPH5301-4-Soft-Touch/dp/B0084D922W

https://www.rcsb.org/structure/6hxw

https://profiles.biocentury.com/products/iph53_iph5301

https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-023-01733-x

https://firstwordpharma.com/story/5856305

https://synapse.patsnap.com/drug/a1fe725ce99149ed989199751fe3073f

https://www.sec.gov/Archives/edgar/data/1598599/000162828022012010/exhibit991-6xk.htm

https://frenchhealthcare.com/innate-pharma-is-working-with-astrazeneca-to-speed-up-the-development-of-its-flagship-molecule-monalizumab/

https://www.medifind.com/conditions/Stomach%20Cancer/5026/clinical-trial/439750348

https://hal.science/hal-02903938v1/document

https://www.springermedizin.de/cd39-cd73-a2ar-pathway-and-cancer-immunotherapy/24087614

https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1486868/pdf

https://www.publicnow.com/view/E38CD3CEA72BFF3F51D53A1F6FB885EF0C013E8F?1747115169

http://www.biotnt.com/en/product/product_1399297.html

https://stockviz.com/en/IPH.PA/quick-ratio

https://www.cancerbiomed.org/content/21/11/995

https://www.morningstar.com/stocks/xpar/iph/quote

https://www.mdpi.com/2073-4409/10/7/1715

https://www.biolabreagent.com/product/99/4638.html?srsltid=AfmBOoq4UeFSnNdiz6M4IPDyIuMfnFt865R4fL9nGioXPQwSwKpaLj2l

https://www.morningstar.com/stocks/pinx/iphyf/quote

https://www.mdpi.com/2073-4409/11/19/3103

https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.866097/full

https://bib-pubdb1.desy.de/record/453696/files/A%20highly%20potent%20CD73%20biparatopic%20antibody%20blocks%20organization%20of%20the%20enzyme%20active%20site%20through%20dual%20mechanisms.pdf

https://www.gurufocus.com/news/1902400/innate-pharma-to-present-adenosine-franchise-iph5201-and-iph5301-at-esmo-io-2022

https://www.kavout.com/stocks/nasdaq-ipha/innate-pharma-sa-sponsored-adr

https://patents.google.com/patent/US20200405813A1/en

https://www.gurufocus.com/term/earning-yield/CHIX:IPHP

https://fr.finance.yahoo.com/quote/IPH.PA/profile/

https://www.nasdaq.com/press-release/innate-pharma-reports-first-quarter-2025-business-update-and-financial-results-2025

https://www.creative-diagnostics.com/producttypelist-290-NT5E.htm?page=2

https://www.marketbeat.com/instant-alerts/innate-pharma-nasdaqipha-stock-price-down-1-should-you-sell-2025-06-18/